When did that happen? What stock?I had a well-tested strategy based on pure mathematics/stochastic.
But the market showed me that the "normally impossible" can still happen![]()
Long ago, around 2015. It was another biotech like the said SRPT, don't remember which one it was, it just was in a very similar situation (awaiting FDA approval). Both SRPT and the other one were small companies then, the IV rose upto about 240% IIRC.When did that happen? What stock?
Biotech Stock?Long ago, around 2015. It was another biotech like the said SRPT, don't remember which one it was, it just was in a very similar situation (awaiting FDA approval). Both SRPT and the other one were small companies then, the IV rose upto about 240% IIRC.

Yeah, biotech or medical or something that. Traded just the options of the underlying stock.Biotech Stock?![]()
Yeah some industries tend to be very volatile, I would avoid pharma, biostocks and everything that is Highley affected by geopolitics (e. G. Energy/fx), no matter how good the backtest is. Also test for robustness.Yeah, biotech or medical or something that. Traded just the options of the underlying stock.
Yeah some industries tend to be very volatile, I would avoid pharma, biostocks and everything that is Highley affected by geopolitics (e. G. Energy/fx), no matter how good the backtest is. Also test for robustness.
So you blew up and lost almost all of your gains but would recommend selling premium on the same stocks that made you blow up? What time frame are we talking about? Spy would give you a 7% return per yearIt depends on what side you sit: an option writer likes high IV as he gets higher credit (ie. the premium is higher). So, companies who need FDA approval, ie. biotech, medical, pharma etc., are IMO ideal for option writers, since, as shown with such FDA events, very high IVs happen...

Run that by me again please.In a nutshell how Cornwall capital made it's seed money.